A multi-centered trial investigating gestational treatment with ursodeoxycholic acid compared to metformin to reduce effects of diabetes mellitus (GUARD): a randomized controlled trial protocol

BACKGROUND: Each year in the UK, approximately 35,000 women develop gestational diabetes mellitus (GDM). The condition increases the risk of obstetric and neonatal complications for mother and child, including preeclampsia, preterm birth, and large for gestational age babies. Biochemical consequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovell, Holly, Mitchell, Alice, Ovadia, Caroline, Pitrelli, Noelia, Briley, Annette, Singh, Claire, Marschall, Hanns-Ulrich, Cruickshank, Kennedy, Murphy, Helen, Seed, Paul, Williamson, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295112/
https://www.ncbi.nlm.nih.gov/pubmed/35854327
http://dx.doi.org/10.1186/s13063-022-06462-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295112/
https://www.ncbi.nlm.nih.gov/pubmed/35854327
http://dx.doi.org/10.1186/s13063-022-06462-y

Ejemplares similares